| Members |
targetComponentId |
| Ophthalmic tissue forceps, reusable |
Ophthalmic tissue forceps |
| Ophthalmic tissue forceps, single-use |
Ophthalmic tissue forceps |
| Ophthalmological disorder |
Disorder of eye proper (disorder) |
| Ophthalmological disorder |
Disorder of eye region (disorder) |
| Ophthalmological disorder |
Disorder of eye proper (disorder) |
| Ophthalmological disorder |
Disorder of orbit proper (disorder) |
| Ophthalmological disorder |
Disorder of eye region (disorder) |
| Ophthalmological disorder |
Disorder of eye region (disorder) |
| Ophthalmological disorder |
Disorder of eye proper (disorder) |
| Ophthalmological monitoring (& disease) |
Eye disorder monitoring |
| Ophthalmological sample |
Specimen from eye region (specimen) |
| Ophthalmological sample |
Specimen from eye |
| Ophthalmologist |
Ophthalmologist (occupation) |
| Ophthalmologist |
Medical ophthalmologist (occupation) |
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography |
Angiography of posterior segment of eye using fluorescein |
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography |
Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography (procedure) |
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography |
Angiography of eye using fluorescein (procedure) |
| Opiate agonist (substance) |
Opioid receptor agonist |
| Opiate agonist (substance) |
Product containing opioid receptor agonist (product) |
| Opiate and narcotic poisoning |
Poisoning caused by opioid receptor agonist |
| Opiate or narcotic poisoning NOS |
Poisoning caused by opioid receptor agonist |
| Opiates |
Measurement of opiate agonist |
| Opioid type drug dependence |
Opium dependence |
| Opioid type drug dependence |
Heroin dependence |
| Opioid type drug dependence |
Morphine dependence |
| Opioid type drug dependence |
Opioid dependence |
| Opioid type drug dependence |
Methadone dependence |
| Opisthorchiasis (& [cat liver fluke infection]) |
Opisthorchiasis |
| Opisthorchis |
Genus Clonorchis (organism) |
| Opisthorchis |
Opisthorchis |
| Opisthorchis species |
Opisthorchis |
| Opium and Morphine |
Product containing opium (medicinal product) |
| Opium and Morphine |
Product containing morphine (medicinal product) |
| Opium+belladonna |
Product containing belladonna alkaloid and opium alkaloid (medicinal product) |
| Opossum |
Family Didelphidae (organism) |
| Opossum |
Didelphis virginiana |
| Opportunistic mycoses |
Opportunistic mycosis |
| Opportunistic mycosis associated with acquired immunodeficiency syndrome |
Opportunistic mycosis co-occurrent with human immunodeficiency virus infection (disorder) |
| Opposition transfer to thumb (& Zancolli) |
Opposition transfer to thumb (procedure) |
| Optic disc vascular anomaly |
Optic disc finding |
| Optic disc vascular anomaly |
Congenital anomaly of optic disc |
| Optic nerve &/or visual path disorders |
Disorder of visual pathways |
| Optic nerve invasion stage N0 |
Optic nerve invasion stage N0 in retinoblastoma (tumor staging) |
| Optic nerve invasion stage N1 |
Optic nerve invasion stage N1 in retinoblastoma (tumor staging) |
| Optic nerve invasion stage N2 |
Optic nerve tumour invasion status in retinoblastoma staging |
| Optic nerve invasion stage N3 |
Optic nerve invasion stage N3 in retinoblastoma (tumor staging) |
| Optic neuritis &/or retrobulbar neuritis |
Retrobulbar neuritis |
| Optic neuritis &/or retrobulbar neuritis |
Optic neuritis |
| Optic neuritis &/or retrobulbar neuritis |
Retrobulbar neuritis |
| Optical layer and corpus striatum |
Corpus striatum structure |
| Optociliary shunt vessels |
Opticociliary vessels |
| Oral &/or salivary &/or jaw diseases |
Disorder of jaw |
| Oral &/or salivary &/or jaw diseases |
Disease of mouth |
| Oral &/or salivary &/or jaw diseases |
Oral cavity, salivary glands and jaw diseases |
| Oral &/or salivary &/or jaw diseases |
Disorder of jaw |
| Oral &/or salivary &/or jaw diseases |
Oral cavity, salivary glands and jaw diseases |
| Oral aphthae |
Aphthous ulcer of mouth (disorder) |
| Oral aphthae |
Aphthous ulcer of mouth (disorder) |
| Oral aphthae |
Aphthous ulceration of skin and/or mucous membrane (disorder) |
| Oral aphthae |
Minor oral aphthous ulceration |
| Oral aphthae |
Aphthous ulceration of skin and/or mucous membrane (disorder) |
| Oral aphthae |
Herpetiform aphthous stomatitis |
| Oral aphthous ulcer (disorder) |
Aphthous ulceration of skin and/or mucous membrane (disorder) |
| Oral aphthous ulcer (disorder) |
Aphthous ulcer of mouth (disorder) |
| Oral aphthous ulcer |
Aphthous ulcer of mouth (disorder) |
| Oral aphthous ulcer |
Aphthous ulceration of skin and/or mucous membrane (disorder) |
| Oral aphthous ulcer |
Aphthous ulceration of skin and/or mucous membrane (disorder) |
| Oral aphthous ulcer |
Aphthous ulcer of mouth (disorder) |
| Oral cavity, dental and salivary finding |
Tooth finding |
| Oral cavity, dental and salivary finding |
Finding of salivary apparatus |
| Oral cavity, dental and salivary finding |
Oral cavity finding (finding) |
| Oral chemotherapy |
Oral chemotherapy |
| Oral contraceptive advice (& [pill check]) |
Oral contraceptive advice |
| Oral contraceptive advice (& [pill check]) |
Pill check |
| Oral dermatological agent overdose |
Overdose |
| Oral dyspraxia |
Oral apraxia (disorder) |
| Oral dyspraxia |
Oral dyspraxia |
| Oral fluid drug of abuse level |
Measurement of substance in oral fluid |
| Oral fluid drug of abuse level |
Measurement of substance in oral fluid |
| Oral fluid drug of abuse level |
Measurement of substance in oral fluid |
| Oral form amitriptyline m/r |
Product containing amitriptyline in oral dose form (medicinal product form) |
| Oral form haloperidol solution |
Product containing haloperidol in oral dose form (medicinal product form) |
| Oral form mirtazapine disintegrating tablet |
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Oral form mirtazapine disintegrating tablet |
Mirtazapine 45 mg orodispersible tablet |
| Oral form mirtazapine disintegrating tablet |
Mirtazapine 15 mg orodispersible tablet |
| Oral form mirtazapine tablet |
Mirtazapine 30 mg oral tablet |
| Oral form mirtazapine tablet |
Mirtazapine 45 mg oral tablet |
| Oral form mirtazapine tablet |
Mirtazapine 15 mg oral tablet |
| Oral form mirtazapine tablet |
Mirtazapine 7.5 mg oral tablet |
| Oral form morphine solution |
Product containing morphine in oral dose form (medicinal product form) |
| Oral hairy leukoplakia |
Oral hairy leukoplakia (disorder) |
| Oral hairy leukoplakia |
Hairy leukoplakia of tongue (disorder) |
| Oral herpetiform aphthous ulceration |
Herpetiform aphthous stomatitis |
| Oral hypoglycemic adverse reaction |
Adverse reaction to biguanide oral hypoglycaemic agent |
| Oral hypoglycemic adverse reaction |
Adverse reaction to sulfonyluric hypoglycemic (disorder) |
| Oral hypoglycemic allergy |
Allergy to biguanide (finding) |
| Oral intake of special dietary food |
Oral intake of food modified for nutrient content |
| Oral liquid |
Oral solution |
| Oral liquid |
Oral suspension |
| Oral mucosa |
Entire oral mucous membrane |
| Oral mucosa |
Oral mucous membrane structure |
FHIR